Associate Professor Naomi Allen
BSc, MSc, DPhil
Associate Professor in Epidemiology
- Clinical Trial Service Unit
Naomi Allen is an Associate Professor in Epidemiology, based in the Clinical Trial Service Unit and Epidemiological Studies Unit. She has worked predominantly on large-scale prospective studies such as EPIC and the Million Women Study and has a keen research interest in the role of diet, hormones and circulating biomarkers in cancer development. She is co-Principal Investigator of the Endogenous Hormones, Nutritional Biomarkers and Prostate Cancer Collaborative Group, which aims to conduct individual pooled analyses of the relationship between circulating biomarkers and prostate cancer risk from cohort studies from around the world. In 2011, she became Senior Epidemiologist for UK Biobank and helps co-ordinate record linkage of routine health-related datasets into the study.
The associations of anthropometric, behavioural and sociodemographic factors with circulating concentrations of IGF-I, IGF-II, IGFBP-1, IGFBP-2, and IGFBP-3 in a pooled analysis of 16,024 men from 22 studies.
Watts EL. et al, (2019), Int J Cancer
Circulating insulin-like growth factor I in relation to melanoma risk in the European prospective investigation into cancer and nutrition.
Bradbury KE. et al, (2019), Int J Cancer, 144, 957 - 966
Identifying dementia outcomes in UK Biobank: a validation study of primary care, hospital admissions and mortality data.
Wilkinson T. et al, (2019), Eur J Epidemiol
Cohort profile: design and methods in the eye and vision consortium of UK Biobank.
Chua SYL. et al, (2019), BMJ Open, 9
A Collaborative Analysis of Individual Participant Data from 19 Prospective Studies Assesses Circulating Vitamin D and Prostate Cancer Risk.
Travis RC. et al, (2019), Cancer Res, 79, 274 - 285